Abstract
Magnetic Resonance Imaging (MRI) employs the use of magnetic field and radio waves to produce images of the body. Quality Control (QC) is essential for ensuring optimal performance of MRI systems, as recommended by American College of Radiology (ACR), American Association of Physicists in Medicine (AAPM), and the International Society of Magnetic Resonance in Medicine (ISMRM). This survey examines the status of MRI systems and QC in Nigeria. Questionnaires were administered through google form to Radiologists, Radiographers, Medical Physicists, and biomedical engineers working in various MRI centers across the country, with a total of 44 responses received from 24 centers. The professional bodies of the professionals involved facilitated the questionnaire administration. The survey results indicate that 1.5T is the most common field strength of MRI systems in the country. 83% of the imaging centers rely solely on the service engineer to keep the MRI operational. Although 71% of the centers have Radiation Safety Advisors (RSA), their services do not include MRI. Moreover, 45% of the centers lack an understanding of the composition and importance of MRI QC. This is due to factors such as the absence of regulatory requirements, high patient workload, no trained personnel, and the unavailability of QC equipment. The findings of this survey highlight the need for improved QC programs in the country to improve image quality and longevity of MRI systems. It also underscores the need for the establishment of a regulatory framework and national policy to ensure the safe use of MRI in Nigeria.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* First Author
Data Availability
All data produced in the present study are available upon reasonable request to the authors
